J. M. Banales, V. Cardinale, and G. Carpino, Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA), Nat Rev Gastroenterol Hepatol, vol.13, pp.261-80, 2016.

S. Rizvi, S. A. Khan, C. L. Hallemeier, R. K. Kelley, and G. J. Gores, Cholangiocarcinoma -evolving concepts and therapeutic strategies, Nat Rev Clin Oncol, vol.15, pp.95-111, 2018.

J. Primrose, R. Palmer, D. H. Prasad, R. Mirza, D. Anthoney et al., Adjuvant capecitabine for biliary tract cancer: The BILCAP randomized study, J Clin Oncol, vol.35, p.4006, 2017.

L. Sulpice, M. Rayar, and M. Desille, Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma, Hepatology, vol.58, pp.1992-2000, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01068717

D. Bergeat, A. Fautrel, and B. Turlin, Impact of stroma LOXL2 overexpression on the prognosis of intrahepatic cholangiocarcinoma, J Surg Res, vol.203, pp.441-50, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01341595

A. Merdrignac, G. Angenard, and C. Allain, A novel transforming growth factor beta-induced long noncoding RNA promotes an inflammatory microenvironment in human intrahepatic cholangiocarcinoma, Hepatol Commun, vol.2, pp.254-69, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01744444

Z. Wangyang, J. Daolin, and X. Yi, J Cancer, vol.9, pp.100-107, 2018.

W. Song, D. L. Miao, and L. Chen, Comprehensive analysis of long noncoding RNA-associated competing endogenous RNA network in cholangiocarcinoma, Biochem Biophys Res Commun, vol.506, pp.1004-1016, 2018.

X. Wang, K. B. Hu, Y. Q. Zhang, C. J. Yang, and H. H. Yao, Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and mRNAs with associated ceRNA network in Cholangiocarcinoma, Cancer Biomark, 2018.

B. W. Han, H. Ye, and P. P. Wei, Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes, BMC Genomics, vol.19, p.735, 2018.

W. Yang, Y. Li, X. Song, J. Xu, and J. Xie, Genome-wide analysis of long noncoding RNA and mRNA coexpression profile in intrahepatic cholangiocarcinoma tissue by RNA sequencing, Oncotarget, vol.8, pp.26591-26600, 2017.

Y. Yu, M. Zhang, and J. Liu, Long Non-coding RNA PVT1 Promotes Cell Proliferation and Migration by Silencing ANGPTL4 Expression in Cholangiocarcinoma, Mol Ther Nucleic Acids, vol.13, pp.503-516, 2018.

Y. Yu, M. Zhang, and N. Wang, Epigenetic silencing of tumor suppressor gene CDKN1A by oncogenic long non-coding RNA SNHG1 in cholangiocarcinoma, Cell Death Dis, vol.9, p.746, 2018.

C. Zhang, J. Y. Li, and F. Z. Tian, Long Noncoding RNA NEAT1 Promotes Growth and Metastasis of Cholangiocarcinoma Cells, Oncol Res, vol.26, pp.879-88, 2018.

M. Parasramka, I. K. Yan, and X. Wang, BAP1 dependent expression of long non-coding RNA NEAT-1 contributes to sensitivity to gemcitabine in cholangiocarcinoma, Mol Cancer, vol.16, p.22, 2017.

Y. Li, Q. Cai, W. Li, F. Feng, and L. Yang, Long non-coding RNA EPIC1 promotes cholangiocarcinoma cell growth, Biochem Biophys Res Commun, vol.504, pp.654-663, 2018.

D. Zhang, H. Li, and J. Xie, Long noncoding RNA LINC01296 promotes tumor growth and progression by sponging miR-5095 in human cholangiocarcinoma, Int J Oncol, vol.52, pp.1777-86, 2018.

Y. Xu, Y. Yao, and K. Leng, Long non-coding RNA UCA1 indicates an unfavorable prognosis and promotes tumorigenesis via regulating AKT/GSK-3beta signaling pathway in cholangiocarcinoma, Oncotarget, vol.8, pp.96203-96217, 2017.

C. Wang, Z. P. Mao, and L. Wang, Long non-coding RNA MALAT1 promotes cholangiocarcinoma cell proliferation and invasion by activating PI3K/Akt pathway, Neoplasma, vol.64, pp.725-756, 2017.

J. G. Bai, R. F. Tang, J. F. Shang, S. Qi, G. D. Yu et al., Upregulation of long noncoding RNA CCAT2 indicates a poor prognosis and promotes proliferation and metastasis in intrahepatic cholangiocarcinoma, Mol Med Rep, 2018.

X. L. Xia, D. Xue, and T. H. Xiang, Overexpression of long non-coding RNA CRNDE facilitates epithelial-mesenchymal transition and correlates with poor prognosis in intrahepatic cholangiocarcinoma, Oncol Lett, vol.15, pp.4105-4117, 2018.

Y. Xu, K. Leng, and Z. Li, The prognostic potential and carcinogenesis of long non-coding RNA TUG1 in human cholangiocarcinoma, Oncotarget, vol.8, pp.65823-65858, 2017.

B. Zheng, S. Jeong, Y. Zhu, L. Chen, and Q. Xia, miRNA and lncRNA as biomarkers in cholangiocarcinoma(CCA), Oncotarget, vol.8, pp.100819-100849, 2017.

J. Shi, X. Li, and F. Zhang, The Plasma LncRNA Acting as Fingerprint in Hilar Cholangiocarcinoma, Cell Physiol Biochem, vol.49, pp.1694-702, 2018.

C. Allain, G. Angenard, B. Clement, and C. Coulouarn, Integrative Genomic Analysis Identifies the Core Transcriptional Hallmarks of Human Hepatocellular Carcinoma, Cancer Res, vol.76, pp.6374-81, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01375429

C. Coulouarn, V. M. Factor, E. A. Conner, and S. S. Thorgeirsson, Genomic modeling of tumor onset and progression in a mouse model of aggressive human liver cancer, Carcinogenesis, vol.32, pp.1434-1474, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00739481

J. S. Lee, I. S. Chu, and J. Heo, Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling, Hepatology, vol.40, pp.667-76, 2004.

L. Sulpice, M. Rayar, and B. Turlin, Epithelial cell adhesion molecule is a prognosis marker for intrahepatic cholangiocarcinoma, J Surg Res, vol.192, pp.117-140, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01069630

K. M. Chan, C. Y. Tsai, and C. N. Yeh, Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence, BMC Gastroenterol, vol.18, pp.125-162, 2017.

J. Shen, W. Wang, and J. Wu, Comparative proteomic profiling of human bile reveals SSP411 as a novel biomarker of cholangiocarcinoma, PLoS One, vol.7, p.47476, 2012.

L. Sulpice, M. Desille, and B. Turlin, Gene expression profiling of the tumor microenvironment in human intrahepatic cholangiocarcinoma, Genom Data, vol.7, pp.229-261, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01259227

Y. Yan, S. Li, and S. Wang, Long noncoding RNA HAND2-AS1 inhibits cancer cell proliferation, migration, and invasion in esophagus squamous cell carcinoma by regulating microRNA-21, J Cell Biochem, 2018.

J. Zhou, J. Lin, H. Zhang, F. Zhu, and R. Xie, LncRNA HAND2-AS1 sponging miR-1275 suppresses colorectal cancer progression by upregulating KLF14, Biochem Biophys Res Commun, vol.503, pp.1848-53, 2018.

C. Gao, W. Lu, W. Lou, L. Wang, and Q. Xu, Long noncoding RNA HOXC13-AS positively affects cell proliferation and invasion in nasopharyngeal carcinoma via modulating miR-383-3p/HMGA2 axis, J Cell Physiol, 2018.

E. Pasmant, I. Laurendeau, D. Heron, M. Vidaud, D. Vidaud et al., Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF, Cancer Res, vol.67, pp.3963-3972, 2007.

Y. Kong, C. H. Hsieh, and L. C. Alonso, ANRIL: A lncRNA at the CDKN2A/B Locus With Roles in Cancer and Metabolic Disease, Front Endocrinol (Lausanne), vol.9, p.405, 2018.

H. Wang, Y. Liu, and J. Zhong, Long noncoding RNA ANRIL as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis, Oncotarget, vol.9, pp.14608-14626, 2018.

L. Hua, C. Y. Wang, K. H. Yao, J. T. Chen, J. J. Zhang et al., High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma, Int J Clin Exp Pathol, vol.8, pp.3076-82, 2015.

F. Aguilo, M. M. Zhou, and M. J. Walsh, Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression, Cancer Res, 2011.

F. Q. Nie, M. Sun, and J. S. Yang, Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression, Mol Cancer Ther, vol.14, pp.268-77, 2015.

E. B. Zhang, R. Kong, and D. D. Yin, Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a, Oncotarget, vol.5, pp.2276-92, 2014.

J. J. Qiu, Y. Wang, Y. L. Liu, Y. Zhang, J. X. Ding et al., The long non-coding RNA ANRIL promotes proliferation and cell cycle progression and inhibits apoptosis and senescence in epithelial ovarian cancer, Oncotarget, vol.7, pp.32478-92, 2016.

H. Zhu, X. Li, Y. Song, P. Zhang, Y. Xiao et al., Long non-coding RNA ANRIL is up-regulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway, Biochem Biophys Res Commun, vol.467, pp.223-231, 2015.

Z. W. Zou, C. Ma, and L. Medoro, LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells, Oncotarget, vol.7, pp.61741-54, 2016.

J. J. Zhao, S. Hao, and L. L. Wang, Long non-coding RNA ANRIL promotes the invasion and metastasis of thyroid cancer cells through TGF-beta/Smad signaling pathway, Oncotarget, vol.7, pp.57903-57921, 2016.

J. Ma, T. Li, X. Han, and H. Yuan, Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma, J Cancer Res Clin Oncol, vol.144, pp.205-219, 2018.

R. Xu, Y. Mao, K. Chen, W. He, W. Shi et al., The long noncoding RNA ANRIL acts as an oncogene and contributes to paclitaxel resistance of lung adenocarcinoma A549 cells, Oncotarget, vol.8, pp.39177-84, 2017.

L. Lin, Z. T. Gu, W. H. Chen, and K. J. Cao, Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis, Diagn Pathol, vol.10, p.14, 2015.

Y. Xie, Y. Zhang, and L. Du, Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer, Mol Oncol, vol.12, pp.648-58, 2018.

N. Soares-do-amaral, E. Cruz, B. De-melo-maia, M. Rocha, and R. , Noncoding RNA Profiles in Tobacco-and Alcohol-Associated Diseases. Genes (Basel), vol.8, 2016.

G. Wan, R. Mathur, and X. Hu, Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway, Cell Signal, vol.25, pp.1086-95, 2013.

Y. Lu, X. Zhou, L. Xu, C. Rong, C. Shen et al., Long noncoding RNA ANRIL could be transactivated by c-Myc and promote tumor progression of non-small-cell lung cancer, Onco Targets Ther, vol.9, pp.3077-84, 2016.

C. Rodriguez, J. Borgel, F. Court, G. Cathala, T. Forne et al., CTCF is a DNA methylation-sensitive positive regulator of the INK/ARF locus, Biochem Biophys Res Commun, vol.392, pp.129-163, 2010.